Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study

BACKGROUND: HER2-positive breast cancer was aggressive, resulting in a poorer prognosis. This multicenter study analyzed the real-world data of women treated with pyrotinib-based therapy, aiming to describe their characteristics, treatment regimens, and to investigate the clinical outcomes. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lili, Wu, Xiaohong, Zhou, Jun, Zhu, Mingzhen, Yu, Hao, Zhang, Yusong, Zhao, Yutian, Han, Zhengxiang, Guo, Yujiang, Guan, Xiaoqing, Wang, Xufen, Xu, Hong, Sun, Li, Zhang, Jiaxin, Zhuang, Min, Xie, Li, Yu, Shiyou, Chen, Ping, Feng, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322968/
https://www.ncbi.nlm.nih.gov/pubmed/34336688
http://dx.doi.org/10.3389/fonc.2021.699323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322968/
https://www.ncbi.nlm.nih.gov/pubmed/34336688
http://dx.doi.org/10.3389/fonc.2021.699323

Ejemplares similares